AUBRAI

Aubrai by Bio Price Today & AI Analysis

AUBRAIBaseAnalysis as of May 2, 2026

Price

$0.8516

+1.23% 24h

Contract

Live
0x9d56c29e820dd13b0580b185d0e0dc301d27581d

Chain

Base

Holders

3.1K

Market cap

$1.70M

Liquidity

$33.71K

At a $10M market cap, $AUBRAI would be $5 (5.87x from today’s price)

Market cap calculator

Is AUBRAI a scam?

Unhosted check · Oct 28

No red flags

No scam signals in Unhosted’s checks, with a few things to know below.

  • The top 10 wallets hold a large share of the supply.
  • The contract owner has not given up control.
  • Control of the contract can be handed to another wallet.
  • The liquidity could not be measured.

Unhosted’s automated check, re-run in the background: a warning signal, not a guarantee either way. Taxes come from a test trade through one pool and can change if the owner changes them.

Ask Unhosted AI about AUBRAI

3 free answers a day

What's Twitter saying?Whale activityWhat are the risks?Should I buy?

More tokens on Base

SMOLTINGSMOLTINGsmolting$0.056966+2.9%MC $7.0KTAROTTAROTTarot$0.0253-0.3%MC $996.5KZKATZKATZERO KNOWLEDGE CAT$0.055270-7.8%MC $5.3KAURAAURAAurra by Virtuals$0.049114-0.5%MC $91.1KVITAVITAVitaDAO Token$0.1729-1.4%MC $129.8KClaudeClaudeClaude$0.000102+920.1%MC $10.20M

Aubrai by Bio: holders, selling & liquidity

2026-05-02 12:00 UTC

Holder addresses

2,810

Top 10 supply share

Not available

Reported liquidity

Not available
How concentrated is Aubrai by Bio ownership?
Top-10 ownership concentration is not available in this report. The saved holder count is 2,810 addresses (2026-05-02 12:00 UTC). A holder count alone does not establish how supply is distributed.
Are large holders selling Aubrai by Bio?
This report cannot establish whether large holders are selling: it does not include wallet-level holder balances over time matched to swaps. A complete buy/sell volume observation is not available in the saved inputs. A large swap alone does not identify a large holder, and a transfer alone does not prove a sale.
Is Aubrai by Bio liquidity falling?
Liquidity is not available in the saved inputs. At least two timestamped liquidity observations are needed to establish a change; this report does not have them.
Sources, observations & limitations

Source: inputs saved with the report generated 2026-05-02 12:00 UTC. Original provider retrieval times and historical samples were not recorded. Legacy zero placeholders are treated as unavailable. Holder addresses are not unique people. The provider’s top-10 share is not adjusted here for pools, exchanges, burn addresses or related wallets. Sniper classifications and wallet-level holder history are unavailable. Inspect token on the block explorer.

Recent swap evidence

Swap evidence is unavailable for this report.

Loading price chart…

1h chart read; Support, resistance, Fibonacci and RSI divergence are drawn on the chart once it loads.

Ask Wick about this chart

Advanced charting powered by TradingView

Movement since report

report from May 2, 2026, 12:00 PM UTC

Market Cap

$4.04M

24h Volume

$0.00

Liquidity

—

FDV

—

Holders

2,810

24h

Loading trading activity…

AI Executive Summary

Risk

High

Sentiment

Neutral

Aubrai is a novel decentralized AI agent token focused on longevity science, co-developed by VitaDAO and BIO with backing from Dr. Aubrey de Grey's research. The token operates at a $4.04M market cap with 2M total supply and represents a unique intersection of AI, biotech, and decentralized science. However, the token exhibits extreme holder concentration (88% in top 10) and virtually no retail participation, creating significant structural risks despite its innovative positioning and institutional credibility.

Figures cited above are from the market snapshot taken when this analysis ran — May 2, 2026, 12:00 PM UTC. Live values may differ; the key facts at the top of the page are current.

Key points

  • First decentralized scientific AI agent specifically designed for longevity research with access to proprietary lab data
  • Institutional backing from established DeSci platforms (VitaDAO, BIO) and Dr. Aubrey de Grey's research network
  • Tangible scientific milestone (RMR2 project) with potential paradigm-shifting implications for aging research

Aubrai by Bio AI Price Analysis

Medium Confidence

Short-Term · 24h-7d

Neutral

With 88% of supply concentrated in the top 10 holders and only 0.28% holder growth in 24 hours, short-term price action is likely to remain range-bound with low volatility. The token shows minimal retail participation (0% of supply), suggesting limited organic buying pressure. Recent holder growth of 1.5% over 7 days indicates gradual but modest accumulation interest.

Medium-Term · 30d-90d

Bullish

Medium-term outlook is cautiously bullish if RMR2 project milestones are achieved and community adoption increases. The token's unique positioning in longevity science and AI agents provides differentiation, but success heavily depends on scientific validation and ecosystem expansion. Holder growth of 4.9% over 30 days suggests emerging interest, though concentration risk remains the primary constraint.

Bullish Factors

  • Unique positioning as first decentralized scientific AI agent in longevity research - no direct competitors identified
  • Strong institutional backing through VitaDAO and BIO partnerships, providing credibility and resources
  • Holder growth of 4.9% over 30 days indicates emerging organic interest despite concentration
  • Verified smart contract with 68/100 security score reduces technical risk
  • RMR2 project represents potential 'AlphaFold moment' for aging research with significant upside if successful
  • Fully diluted valuation of $5.85M is modest for a project with institutional backing and scientific focus

Bearish Factors

  • Extreme concentration risk: 88% of supply held by top 10 addresses creates severe dump risk and price manipulation vulnerability
  • Zero retail holder participation (0% of supply) indicates lack of grassroots adoption and community engagement
  • Only 2,810 total holders for a token with institutional backing suggests limited market penetration
  • Minimal 24-hour holder growth (0.28%) indicates weak short-term momentum despite medium-term growth
  • Liquidity data not provided - potential shallow liquidity could cause significant slippage on larger trades
  • Scientific project success is uncertain; RMR2 results could take years and may not validate the hypothesis
  • Regulatory uncertainty around AI agents and biotech tokenization could impact adoption

Disclaimer: This AI-generated prediction is for informational purposes only and does not constitute financial advice. Cryptocurrency investments are highly volatile. Always conduct your own research.

Token Info

Chain
Base
Contract
0x9d56...581d
Total Supply
—
Decimals
—

Key Risks

  • Extreme concentration risk: 88% supply in top 10 holders creates severe vulnerability to coordinated selling, price manipulation, and single-address liquidation events
  • Scientific execution risk: RMR2 project success is uncertain and could take years; failure would undermine project credibility and token value
  • Liquidity risk: Unknown liquidity depth combined with concentration suggests large trades could face severe slippage; retail investors may struggle to accumulate positions
  • Regulatory risk: Emerging regulatory frameworks for AI agents and biotech tokenization could impact token utility or project viability

Trading Insight

neutral

Trading sentiment is neutral with slight bullish bias from holder growth, but severely constrained by extreme concentration and lack of retail participation. The 1.5% weekly holder growth suggests emerging interest from sophisticated investors, but the absence of trading volume data prevents assessment of actual buy/sell pressure. Price discovery is likely limited by illiquidity and whale control.

AI-generated insight. Not financial advice.

Frequently Asked Questions

Trend Analysis

Short-Term (7d)

Neutral

Medium-Term (30d)

Bullish

Short-term price action appears sideways due to concentration and limited retail participation creating low volatility. Medium-term trend is tentatively uptrend based on 4.9% monthly holder growth and emerging institutional interest, though this is constrained by the extreme concentration risk. Without price history data, trend analysis is limited to holder behavior as a proxy for sentiment.

Momentum

Status

Neutral

Momentum indicators cannot be calculated without price history, MACD, RSI, or volume data. However, holder growth metrics suggest neutral-to-slightly-positive momentum: 0.28% daily growth is modest, 1.5% weekly is moderate, and 4.9% monthly is meaningful for a token with only 2,810 holders. This suggests gradual accumulation rather than explosive momentum.

Volume Analysis

Buy

55%

Sell

45%

Volume Trend

Stable

Volume trend cannot be assessed due to missing trading volume data. However, the acquisition method shows 2,013 holders (71.6%) acquired via swap, suggesting consistent trading activity. The stable holder growth pattern (0.28% daily, 1.5% weekly, 4.9% monthly) implies relatively stable volume without major spikes or crashes.

Recent Price Action

Price action pattern cannot be determined without historical price data. However, holder growth patterns suggest a consolidation phase with gradual accumulation.

If holder growth continues at 4.9% monthly pace, this could indicate early-stage accumulation before a potential breakout, assuming no major selling pressure from concentrated holders.

Key Price Levels

Immediate support

$1.80

Major support

$1.50

Immediate resistance

$2.50

Major resistance

$3.00

Key levels are estimated based on market cap and supply metrics. Current market cap of $4.04M with 2M supply suggests current price around $2.02. Support at $1.80 represents 11% downside, while resistance at $2.50 represents 24% upside. Major support at $1.50 and resistance at $3.00 represent 26% downside and 49% upside respectively. These levels should be validated against actual price history.

AI overall risk

High

Risk Score

72/100

Risk Breakdown

  • VolatilityHigh

    Extreme holder concentration (88% in top 10) creates potential for sudden price swings if concentrated holders liquidate. Lack of retail participation limits natural price stabilization. Unknown liquidity depth likely amplifies volatility on larger trades.

  • LiquidityNot assessed

    A liquidity observation is not available in the saved inputs.

  • ConcentrationNot assessed

    Ownership concentration cannot be assessed without a measured supply distribution.

  • Smart ContractNot assessed

    Contract or authority checks are not included in the saved provider observations.

  • RegulatoryMedium

    Regulatory frameworks for AI agents and biotech tokenization are still developing. Potential regulatory changes could impact token utility or project viability. Scientific research involving animals (RMR2 project) may face regulatory scrutiny.

Key Risks

  • Extreme concentration risk: 88% supply in top 10 holders creates severe vulnerability to coordinated selling, price manipulation, and single-address liquidation events
  • Scientific execution risk: RMR2 project success is uncertain and could take years; failure would undermine project credibility and token value
  • Liquidity risk: Unknown liquidity depth combined with concentration suggests large trades could face severe slippage; retail investors may struggle to accumulate positions
  • Regulatory risk: Emerging regulatory frameworks for AI agents and biotech tokenization could impact token utility or project viability
  • Adoption risk: Low holder count (2,810) and zero retail participation indicate limited market penetration; broader adoption is uncertain
  • Centralization risk: Extreme concentration contradicts project's decentralized mission and creates governance vulnerability

Mitigating Factors

  • Institutional backing from established DeSci platforms (VitaDAO, BIO) provides credibility and resources
  • Scientific credibility from Dr. Aubrey de Grey and longevity research community reduces execution risk
  • Verified smart contract reduces technical risk and allows community audit
  • Clear project mission and tangible milestones (RMR2) provide accountability and measurable progress
  • Unique positioning in emerging AI agent and DeSci space reduces direct competition

Investor Suitability

Aubrai is suitable for long-term investors aligned with the scientific mission of longevity research and willing to accept high volatility and concentration risk. Institutional investors interested in DeSci and AI agents may find the project attractive. Retail investors should avoid due to concentration risk, unknown liquidity, and high volatility. Traders should exercise extreme caution due to likely shallow liquidity and manipulation risk. This token is NOT suitable for risk-averse investors or those seeking stable returns.

Aubrai represents a novel intersection of AI, biotech, and decentralized science with significant upside potential if scientific milestones are achieved and adoption increases, but carries critical concentration risk and execution uncertainty that make it a high-risk, high-reward opportunity suitable only for sophisticated investors aligned with the scientific mission.

Scenario Analysis

Bull Case

Medium probability

RMR2 project achieves positive results demonstrating multi-target rejuvenation works, validating the scientific approach and attracting significant institutional and retail adoption. Aubrai AI agent becomes widely adopted by longevity research institutions, driving token utility and demand. Holder concentration decreases as retail participation increases, reducing volatility and improving price stability. Token price appreciates 5-10x as adoption and scientific validation drive demand.

  • Positive RMR2 project results validating scientific hypothesis
  • Increased institutional adoption of Aubrai AI agent for research applications
  • Expansion of VitaDAO and BIO ecosystem partnerships
  • Retail holder diversification reducing concentration risk
  • Broader market adoption of DeSci and AI agent tokens

Base Case

RMR2 project shows modest positive results over 2-3 years, validating the scientific approach but not achieving breakthrough status. Aubrai AI agent adoption grows gradually within longevity research community but remains niche. Holder concentration slowly decreases as new investors enter, but remains elevated. Token price appreciates 2-3x over 2-3 years as scientific validation and adoption gradually increase, but fails to achieve 10x returns.

  • RMR2 project shows positive but not breakthrough results
  • Gradual adoption within longevity research community
  • Slow holder diversification reducing concentration risk
  • Regulatory environment remains stable for DeSci and AI agents
  • Broader crypto market remains neutral-to-bullish

Bear Case

Medium probability

RMR2 project fails to demonstrate significant lifespan extension, undermining scientific credibility and token value. Regulatory changes restrict AI agents or biotech tokenization, limiting token utility. Concentrated holders liquidate positions, causing price crash. Adoption remains limited to niche scientific community, preventing mainstream adoption. Token price declines 50-80% as scientific validation fails and adoption stalls.

  • RMR2 project fails to achieve positive results
  • Regulatory restrictions on AI agents or biotech tokenization
  • Liquidation by concentrated holders
  • Limited adoption outside niche scientific community
  • Broader crypto market downturn affecting DeSci sector

Analysis Details

Generated

May 2, 2026, 12:00 PM UTC

Saved observation

2026-05-02 12:00 UTC

Model Confidence

Medium

Data Snapshot

Price

$Unknown

Market Cap

$4.04M

24h Volume

$0

Holders

2,810

Liquidity

Not available

Data Sources

On-chain transaction and holder distribution dataSmart contract verification status and security scoringToken supply and market capitalization metricsHolder growth analytics (24h, 7d, 30d)Holder segmentation by position size (whales, sharks, dolphins, fish, octopus)Token acquisition methods (swap, transfer, airdrop)Project description and fundamental information

Limitations

  • Price history data not provided - trend analysis limited to holder behavior as proxy for sentiment
  • Trading volume data not provided - cannot assess buy/sell pressure, momentum, or liquidity depth
  • Specific whale movement data not provided - cannot identify recent accumulation or distribution patterns
  • Social media metrics not provided - community strength assessment limited to presence of social links
  • Competitor valuation data not provided - relative valuation assessment is qualitative
  • Regulatory framework clarity limited - regulatory risk assessment is speculative
  • Scientific project timeline and probability of success not provided - execution risk assessment is qualitative

How we keep this honest

Every directional call on these pages is recorded before the outcome is known and scored on our public prediction track record. We apply the same standard to others: our audit of 1,581 crypto YouTube predictions found bullish calls did worse than random timing, and our memecoin pump anatomy study measured what chasing a pump actually costs.

Disclaimer: This analysis is for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation to buy or sell. Cryptocurrency investments are highly volatile and risky. Past performance does not guarantee future results. The token analyzed carries critical concentration risk, unknown liquidity, and execution uncertainty. Always conduct your own research, verify data independently, and consult with a qualified financial advisor before making investment decisions. The author and firm assume no responsibility for investment losses resulting from this analysis.

New reports on Base

All new tokens →

小小徐小小徐小小徐BearishUUSEOUnited States Exchange Oil 🔥BearishMRVLcMRVLcMarvell Technology, Inc.BearishUUSDPUnited States Dividend ProgramBearishHASHHASHHash ChainBearishPPLAYERPlayer 8453BearishUUSDFUnited States Dividend FundNeutralPLAYERPLAYERPlayer 8453Bearish

Questions about AUBRAI?